Literature DB >> 11118240

Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study.

F E de Leeuw1, J C de Groot, E Achten, M Oudkerk, L M Ramos, R Heijboer, A Hofman, J Jolles, J van Gijn, M M Breteler.   

Abstract

OBJECTIVE: White matter lesions are often seen on MR scans of elderly non-demented and demented people. They are attributed to degenerative changes of small vessels and are implicated in the pathogenesis of cognitive decline and dementia. There is evidence that especially periventricular white matter lesions are related to cognitive decline, whereas subcortical white matter lesions may be related to late onset depression. The frequency distribution of subcortical and periventricular white matter lesions according to age and sex reported.
METHODS: A total of 1077 subjects aged between 60-90 years were randomly sampled from the general population. All subjects underwent 1.5T MR scanning; white matter lesions were rated separately for the subcortical region and the periventricular region.
RESULTS: Of all subjects 8% were completely free of subcortical white matter lesions, 20% had no periventricular white matter lesions, and 5% had no white matter lesions in either of these locations. The proportion with white matter lesions increased with age, similarly for men and women. Women tended to have more subcortical white matter lesions than men (total volume 1.45 ml v 1. 29 ml; p=0.33), mainly caused by marked differences in the frontal white matter lesion volume (0.89 ml v 0.70 ml; p=0.08). Periventricular white matter lesions were also more frequent among women than men (mean grade 2.5 v 2.3; p=0.07). Also severe degrees of subcortical white matter lesions were more common in women than in men (OR 1.1; 95% confidence interval (95% CI) 0.8-1.5) and periventricular white matter lesions (OR 1.2; 95% CI 0.9-1.7), albeit that none of these findings were statistically significant.
CONCLUSIONS: The prevalence and the degree of cerebral white matter lesions increased with age. Women tended to have a higher degree of white matter lesions than men. This may underlie the finding of a higher incidence of dementia in women than in men, particularly at later age.

Entities:  

Mesh:

Year:  2001        PMID: 11118240      PMCID: PMC1763449          DOI: 10.1136/jnnp.70.1.9

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  32 in total

1.  Cerebral white matter lesions and cognitive function: the Rotterdam Scan Study.

Authors:  J C de Groot; F E de Leeuw; M Oudkerk; J van Gijn; A Hofman; J Jolles; M M Breteler
Journal:  Ann Neurol       Date:  2000-02       Impact factor: 10.422

2.  St. Vitus' dance and rheumatic disease.

Authors:  D C Schechter
Journal:  N Y State J Med       Date:  1975-06

3.  Estrogens as antioxidants.

Authors:  E Niki; M Nakano
Journal:  Methods Enzymol       Date:  1990       Impact factor: 1.600

4.  Development of dementing illnesses in an 80-year-old volunteer cohort.

Authors:  R Katzman; M Aronson; P Fuld; C Kawas; T Brown; H Morgenstern; W Frishman; L Gidez; H Eder; W L Ooi
Journal:  Ann Neurol       Date:  1989-04       Impact factor: 10.422

5.  1H chemical shift imaging of the human brain at age 60-90 years reveals metabolic differences between women and men.

Authors:  P E Sijens; M Oudkerk; F E de Leeuw; J C de Groot; E Achten; R Heijboer; A Hofman; M M Breteler
Journal:  Magn Reson Med       Date:  1999-07       Impact factor: 4.668

6.  Do white matter changes on MRI and CT differentiate vascular dementia from Alzheimer's disease?

Authors:  T Erkinjuntti; L Ketonen; R Sulkava; J Sipponen; M Vuorialho; M Iivanainen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-01       Impact factor: 10.154

7.  A follow-up study of blood pressure and cerebral white matter lesions.

Authors:  F E de Leeuw; J C de Groot; M Oudkerk; J C Witteman; A Hofman; J van Gijn; M M Breteler
Journal:  Ann Neurol       Date:  1999-12       Impact factor: 10.422

8.  Stopped-flow investigation of antioxidant activity of estrogens in solution.

Authors:  K Mukai; K Daifuku; S Yokoyama; M Nakano
Journal:  Biochim Biophys Acta       Date:  1990-09-14

9.  White matter hyperintensities in dementia of Alzheimer's type and in healthy subjects without cerebrovascular risk factors. A magnetic resonance imaging study.

Authors:  W E Kozachuk; C DeCarli; M B Schapiro; E E Wagner; S I Rapoport; B Horwitz
Journal:  Arch Neurol       Date:  1990-12

10.  Raised blood pressure and plasma noradrenaline concentrations in teenagers and young adults selected from an open population.

Authors:  A Hofman; F Boomsma; M A Schalekamp; H A Valkenburg
Journal:  Br Med J       Date:  1979-06-09
View more
  353 in total

1.  In Vivo Imaging of Venous Side Cerebral Small-Vessel Disease in Older Adults: An MRI Method at 7T.

Authors:  C E Shaaban; H J Aizenstein; D R Jorgensen; R L MacCloud; N A Meckes; K I Erickson; N W Glynn; J Mettenburg; J Guralnik; A B Newman; T S Ibrahim; P J Laurienti; A N Vallejo; C Rosano
Journal:  AJNR Am J Neuroradiol       Date:  2017-08-03       Impact factor: 3.825

2.  Leukoaraiosis on magnetic resonance imaging is related to long-term poor functional outcome after thrombolysis in acute ischemic stroke.

Authors:  Jae Hyung Choi; Hyo-Jin Bae; Jae Kwan Cha
Journal:  J Korean Neurosurg Soc       Date:  2011-08-31

3.  Distinct profiles of brain and cognitive changes in the very old with Alzheimer disease.

Authors:  N H Stricker; Y-L Chang; C Fennema-Notestine; L Delano-Wood; D P Salmon; M W Bondi; A M Dale
Journal:  Neurology       Date:  2011-08-10       Impact factor: 9.910

Review 4.  Disconnected aging: cerebral white matter integrity and age-related differences in cognition.

Authors:  I J Bennett; D J Madden
Journal:  Neuroscience       Date:  2013-11-23       Impact factor: 3.590

5.  Effect of diabetes on brain structure: the action to control cardiovascular risk in diabetes MR imaging baseline data.

Authors:  R Nick Bryan; Michel Bilello; Christos Davatzikos; Ronald M Lazar; Anne Murray; Karen Horowitz; James Lovato; Michael E Miller; Jeff Williamson; Lenore J Launer
Journal:  Radiology       Date:  2014-04-29       Impact factor: 11.105

6.  Morphological features of MS lesions on FLAIR* at 7 T and their relation to patient characteristics.

Authors:  Iris D Kilsdonk; Alexandra Lopez-Soriano; Joost P A Kuijer; Wolter L de Graaf; Jonas A Castelijns; Chris H Polman; Peter R Luijten; Jeroen J J G Geurts; Frederik Barkhof; Mike P Wattjes
Journal:  J Neurol       Date:  2014-04-29       Impact factor: 4.849

7.  Age and Alzheimer's pathology disrupt default mode network functioning via alterations in white matter microstructure but not hyperintensities.

Authors:  Christopher A Brown; Yang Jiang; Charles D Smith; Brian T Gold
Journal:  Cortex       Date:  2018-04-19       Impact factor: 4.027

8.  Anatomical mapping of white matter hyperintensities (WMH): exploring the relationships between periventricular WMH, deep WMH, and total WMH burden.

Authors:  Charles DeCarli; Evan Fletcher; Vincent Ramey; Danielle Harvey; William J Jagust
Journal:  Stroke       Date:  2004-12-02       Impact factor: 7.914

9.  Myelin loss in white matter hyperintensities and normal-appearing white matter of cognitively impaired patients: a quantitative synthetic magnetic resonance imaging study.

Authors:  Mina Park; Yeonsil Moon; Seol-Heui Han; Ho Kyun Kim; Won-Jin Moon
Journal:  Eur Radiol       Date:  2018-11-28       Impact factor: 5.315

10.  Differential impact of cerebral white matter changes, diabetes, hypertension and stroke on cognitive performance among non-disabled elderly. The LADIS study.

Authors:  Ana Verdelho; Sofia Madureira; José M Ferro; Anna-Maria Basile; Hugues Chabriat; Timo Erkinjuntti; Franz Fazekas; Michael Hennerici; John O'Brien; Leonardo Pantoni; Emilia Salvadori; Philip Scheltens; Marieke C Visser; Lars-Olof Wahlund; Gunhild Waldemar; Anders Wallin; Domenico Inzitari
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-04-30       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.